Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$10.41−1.33 (-11.33%)
Close on Nov 18, 2026Market cap $70.68MP/E –Yield –
Eloxx Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Eloxx Pharmaceuticals's revenue for the twelve months ending Jun 30, 2012 was $200.00K. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $6.36M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | -100.0% |
| FY2024 | Dec 31, 2024 | $6.36M | – |
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2014 | Jun 30, 2014 | $182.23K | +2230.6% |
| FY2013 | Jun 30, 2013 | $7.82K | -96.1% |
| FY2012 | Jun 30, 2012 | $200.00K | +42.9% |
| FY2010 | Jun 30, 2010 | $140.00K | – |
See a number that looks wrong?